Accelerated Approval Episodes
July 25, 2023
Prior Authorization Consequences + Fast-Tracked FDA Approvals
MacKay Jimeson, Acting Executive Director of Patients Rising Now, wants lawmakers to stand behind the accelerated approval program; Jody Quinn, a patient from Massachusetts’ 13th congressional district who lives with psoriatic disease, says ...
None
July 20, 2023
Accelerated Approval on the Hill
MacKay Jimeson, Acting Executive Director of Patients Rising Now, previews Monday’s accelerated approval hill briefing, which is open for staff to attend; Mel Mann, the longest-living Gleevec patient, discusses how accelerated approval saved his...
None
July 13, 2023
AI Privacy Concerns + Accelerated Approval Benefits
Brett Meeks, Executive Director of the Health Innovation Alliance, is working to make sure everyone gets on the same page on the issue of health privacy and AI; The Pioneer Institute on Public Policy Research will host a webinar next week; Patients...
None
July 11, 2023
Alzheimer’s Breakthrough + Biosimilar Landscape
Sue Peschin, President and CEO of the Alliance for Aging Research, says Medicare coverage for Alzheimer’s drugs is something millions across the country truly care about as an election year nears; the Biden Administration is taking action to limit...
None
April 4, 2023
Accelerated Approval Pathway for ALS Drug, Copay Accumulators Under Review
Rich Brennan, Vice President of Federal Affairs for the ALS Association, explains the approval pathway for Tofersen, a new ALS drug, and what that means for patients; Peter Pitts, President and co-founder of the Center for Medicine in the Public...
None